BOSTON - Insurers claim in an antitrust class action that Astellas Pharma gouged prices and illegally blocked entry of generic Prograf (tacrolimus), used to suppress organ rejection in transplants.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026